Supra-annular implantation of a bioprosthetic aortic valve demonstrated lower pressure gradients, larger orifice area, and reduced shear-induced stress compared to intra-annular deployment in a computational model.
Does supra-annular positioning of a bioprosthetic aortic valve improve hemodynamics compared to intra-annular positioning in a patient-specific computational model?
Computational modeling suggests supra-annular deployment of bioprosthetic aortic valves provides superior hemodynamics and lower hemolysis risk compared to intra-annular deployment.
Aortic valve replacement is a key surgical procedure for treating aortic valve pathologies, such as stenosis and regurgitation. The precise placement of the prosthetic valve relative to the native aortic annulus plays a critical role in the post-operative hemodynamics. This study investigates how the positioning of a biological prosthetic valve -- either intra-annular (within the native annulus) or supra-annular (slightly downstream, in the widened portion of the aortic root) -- affects cardiac fluid dynamics. Using high-fidelity numerical simulations on a patient-specific left heart model derived from CT imaging, we simulate physiological flow conditions to isolate the impact of valve placement. Unlike previous clinical studies that compare different patients and valve models, our approach evaluates the same valve in both positions within a single virtual patient, ensuring a controlled comparison. Key hemodynamic parameters are assessed, including transvalvular pressure drop, effective orifice area, wall shear stress, and hemolysis. Results reveal that supra-annular implantation offers significant advantages: lower pressure gradients, larger orifice area, and reduced shear-induced stress. Furthermore, hemolysis analysis using advanced red blood cell stress models indicates a decreased risk of blood damage in the supra-annular configuration. These findings offer valuable insights to guide valve selection and implantation strategies, ultimately supporting improved patient outcomes.
Scarpolini et al. (Thu,) conducted a other in Aortic valve disease (simulated) (n=1). Supra-annular bioprosthetic aortic valve deployment vs. Intra-annular deployment (DE = 21 mm, DI = 18.6 mm) was evaluated on Hemodynamic performance (transvalvular pressure drop, effective orifice area, wall shear stress, and hemolysis). Supra-annular implantation of a bioprosthetic aortic valve demonstrated lower pressure gradients, larger orifice area, and reduced shear-induced stress compared to intra-annular deployment in a computational model.